Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes

Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients

(2022) Shiela McCollam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CYP2C19 Metabolizer Status Does Not Influence the Safety or Efficacy of Pentamidine

(2020) Nicholas Ambrosino et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study

(2020) Wedad B. Awad et al.   BMC INFECTIOUS DISEASES

Evaluation of CYP2C19 Genotype‐guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant

(2019) Jai N. Patel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era

(2019) Christopher Evernden et al.   CYTOTHERAPY

Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

(2018) Melissa Quinn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

(2018) Wei Zhao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

(2018) Nihal El Rouby et al.   Expert Opinion on Drug Metabolism & Toxicology

IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant

(2015) M J Lim et al.   BONE MARROW TRANSPLANTATION

Low-dose trimethoprim–sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT

(2011) T Muto et al.   BONE MARROW TRANSPLANTATION

Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration

(2011) Lawrence B. Afrin et al.   CLINICAL TRANSPLANTATION

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

(2009) Marcie Tomblyn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION